Post-approval studies (Phase 4)UnknownNCT01651663What this trial is testingArbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common ColdWho this might be right forInfluenza Pharmstandard 840
Post-approval studies (Phase 4)Study completedNCT03143101What this trial is testingEvaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of AgeWho this might be right forInfluenzaHealthy MedImmune LLC 200
Post-approval studies (Phase 4)Study completedNCT01404182What this trial is testingTolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly PersonsWho this might be right forInfluenza Fluart Innovative Vaccine Ltd, Hungary 121
Not applicableStudy completedNCT01459276What this trial is testingEvaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly SubjectsWho this might be right forInfluenza Fluart Innovative Vaccine Ltd, Hungary 1,206
Not applicableStudy completedNCT01008020What this trial is testingEffects of Tea Catechin Consumption on the Prophylaxis of Influenza InfectionWho this might be right forInfluenza Infection Masahiro Morikawa 200
Post-approval studies (Phase 4)Study completedNCT03301155What this trial is testingClinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVIWho this might be right forPreventive Medicine Materia Medica Holding 1,036
Not applicableStudy completedNCT00570037What this trial is testingFeasibility of Cocooning Immunization Strategy With Influenza VaccineWho this might be right forInfluenza Duke University 544
Early research (Phase 1)Study completedNCT00136331What this trial is testingStudy of a Pandemic Influenza VaccineWho this might be right forInfluenza Seqirus 400
Not applicableStudy completedNCT01156701What this trial is testingProphylactic Efficacy of Relenza Against Influenza A and BWho this might be right forPulmonary Disease, Chronic ObstructiveBronchospasmInfluenza, Human+7 more GlaxoSmithKline 171,705
Testing effectiveness (Phase 2)UnknownNCT05284851What this trial is testingThe Safety and Immunogenicity Evaluation of Live Attenuated Influenza VaccineWho this might be right forInfluenza Prevention Changchun BCHT Biotechnology Co. 2,520
Early research (Phase 1)Study completedNCT05401305What this trial is testingSafety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type bWho this might be right forHaemophilus Influenzae InfectionVaccines St. Petersburg Research Institute of Vaccines and Sera 60
Large-scale testing (Phase 3)Study completedNCT00197288What this trial is testingStudy Comparing the Immune Response of Fluarix and Fluzone Influenza VaccinesWho this might be right forInfluenza GlaxoSmithKline 1,847
Early research (Phase 1)Study completedNCT00722774What this trial is testingSafety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus VaccineWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 22
Post-approval studies (Phase 4)Study completedNCT03564444What this trial is testingD2560C00015 FluMist Annual Safety Study 2018Who this might be right forInfluenzaHealthy MedImmune LLC 300
Post-approval studies (Phase 4)UnknownNCT01053377What this trial is testingA Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing HomesWho this might be right forInfluenza National Institute for Public Health and the Environment (RIVM) 900
Testing effectiveness (Phase 2)Study completedNCT06873282What this trial is testingPhase 2 Study of the ТВ/Flu-05Е Tuberculosis VaccineWho this might be right forTuberculosis Research Institute of Influenza, Russia 160
Large-scale testing (Phase 3)Study completedNCT05071313What this trial is testingAn Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and OlderWho this might be right forInfluenza, Human PreventionRespiratory Syncytial Viruses Prevention Janssen Vaccines & Prevention B.V. 777
Not applicableStudy completedNCT01100294What this trial is testingTolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in ChildrenWho this might be right forInfluenza Fluart Innovative Vaccine Ltd, Hungary 10
Testing effectiveness (Phase 2)Study completedNCT00537524What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 YearsWho this might be right forProphylaxis of Avian Influenza Novartis Vaccines 471
Large-scale testing (Phase 3)Study completedNCT01961960What this trial is testingEvaluate Intramuscular ASP7374Who this might be right forInfluenzaVaccine UMN Pharma Inc. 55